{ }
001122334455554433221100
001122334455554433221100

Truist Securities enhances biotech research team with new managing director

Truist Securities has enhanced its biotech equity research team with the addition of Danielle Brill as managing director. Brill, previously a research analyst at Raymond James, brings extensive experience in neurology, hematology, and autoimmune diseases, complementing the firm's existing analysts. This move is part of Truist's strategy to expand its capabilities in high-growth industries and better serve institutional clients.

truist securities expands biotech research team with new analyst appointment

Truist Securities has enhanced its biotech equity research team with the addition of Danielle Brill, who brings extensive experience from her previous roles at Raymond James and other firms. Brill's insights will support the firm's institutional clients in navigating the evolving biotech landscape, alongside a growing team of experts in various sectors. The firm aims to leverage new technologies and high-touch service to deliver differentiated, data-driven content to its clients.
Trending
Subcategory
Countries:
Companies:
Currencies:
People:

Machinary offers a groundbreaking, modular, and customizable solution that provides advanced financial news and statistical analysis. Our platform goes beyond traditional quantitative analysis, offering users a comprehensive understanding of real-time market dynamics, event detection, and risk analysis.

Address

Newsletter

© 2025 by Machinary.com - Version: 1.0.0.0. All rights reserved

Layout

Color mode

Theme mode

Layout settings

Client connection lost

Please check your connection. We try to reconnect...

Server connection lost

If our server is updating to a new version, please wait a moment before the service is available again.

Connection refused

All connection attempts have been rejected. This is most likely due to network problems or server problems.